Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit

PHASE4TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

December 31, 2021

Conditions
Heart Failure
Interventions
DRUG

Ivabradine

At discharge from the observation unit, subjects will receive a pill bottle containing oral capsules containing active drug to take at home. This arm will require the subject to take the study medication BID for the duration of the study period. Neither study team nor subject will know if the pill bottle contains active drug or placebo.

DRUG

Placebo

At discharge from the observation unit, subjects will receive a pill bottle containing oral capsules not containing active drug to take at home. This arm will require the subject to take the study medication BID for the duration of the study period. Neither study team nor subject will know if the pill bottle contains active drug or placebo.

Trial Locations (2)

48201

Wayne State University, Detroit

48202

Henry Ford Hospital, Detroit

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

iRhythm Technologies, Inc.

INDUSTRY

lead

Phillip Levy

OTHER